Solid Biosciences
SLDB
$8.95
Share price
-3.76%
Change (1 day)
45.53%
Change (1 year)
Categories
Solid Biosciences (SLDB) - Cash on Hand
Cash on Hand as of December 2023 : $0.12 B
According to Solid Biosciences
's latest financial reports the company has $0.12 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Solid Biosciences - Cash on Hand chart (from 2016 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.12 B | -42.15% |
| 2022-12-31 | $0.21 B | 2.86% |
| 2021-12-31 | $0.20 B | 34.27% |
| 2020-12-31 | $0.15 B | 85.27% |
| 2019-12-31 | $83.52 M | -31.8% |
| 2018-12-31 | $0.12 B | 77.24% |
| 2017-12-31 | $69.09 M | 83.48% |
| 2016-12-31 | $37.65 M | -32.01% |
| 2015-12-31 | $55.38 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 68.38% | 🇺🇸 USA |